Psoriatic plaques exhibit red autofluorescence that is due to protoporphyrin IX.
In evaluating the autofluorescence properties of normal and diseased skin we discovered that psoriatic plaques can emit a distinct red fluorescence when illuminated with UVA or blue light. Using a macrospectrofluorometer equipped with a 442 nm excitation laser, a sharp in vivo fluorescence emission peak around 635 nm could be demonstrated within the plaques of 34 of 75 (45%) patients with psoriasis. This peak was absent from normal appearing skin of psoriatic patients and also from the skin of 66 patients with other dermatologic diseases. A microspectrofluorometer coupled with the same excitation laser was used to obtain emission spectra of separated epidermal sheets and dermis from plaques demonstrating macroscopic red autofluorescence. An emission peak around 635 nm was observed in all three patients thus studied, but only on spectra obtained from the epidermis. Additional spectra of vertical microscopic sections of intact psoriatic skin from five other patients revealed that the peak originated from the stratum corneum. Emission spectra from other microlocations including the mid-epidermis and dermis of psoriatic and normal skin, as well as the stratum corneum of normal skin, failed to demonstrate a 635 nm peak. The excitation and emission fluorescence spectra of acid extracts of psoriatic scale from five patients were all similar to those of protoporphyrin IX in acid solution. High performance liquid chromatography identified the presence of protoporphyrin IX in the acid extracts from psoriatic scale of the same patients. We conclude that native psoriatic plaques can exhibit red autofluorescence that is due to elevated levels of protoporphyrin IX within scales.
Bissonnette
R
R
Division of Dermatology, University of British Columbia and Vancouver Hospital and Health Sciences Centre, Canada.
Zeng
H
H
McLean
D I
DI
Schreiber
W E
WE
Roscoe
D L
DL
Lui
H
H
D005453:Fluorescence; D006801:Humans; D017319:Photosensitizing Agents / Q000032:analysis / Q000494:pharmacology*; D011524:Protoporphyrins / Q000032:analysis / Q000494:pharmacology*; D011565:Psoriasis / Q000378:metabolism*; D012867:Skin / Q000737:chemistry; D013050:Spectrometry, Fluorescence
D017319:Photosensitizing Agents; D011524:Protoporphyrins; C028025:protoporphyrin IX